Allos Therapeutics Inc. (NASDAQ: ALTH) shares traded as much as 28% higher amid news that rival Spectrum Pharmaceuticals (NASDAQ: SPPI) has agreed to buy the company for $206 million, or $1.82 a share. The deal is expected to give Spectrum access to Allos’s anti-cancer drug Folotyn. Spectrum’s move followed news that its experimental drug to treat a common form of bladder cancer failed to significantly reduce the recurrence of tumors in late-stage trials.

ALTH added $0.39 to close at $1.83 on strong volume of 82.73 million shares. The stock has advanced 23.47% over the last five days. SPPI dropped 9.42% to $11.06 on volume of 9.27 million shares.

Allos Therapeutics is a biopharmaceutical company committed to the development and commercialization of innovative anti-cancer therapeutics. Allos is currently focused on the development and commercialization of Folotyn (pralatrexate injection), a folate analogue metabolic inhibitor. Folotyn is approved in the U.S. for the treatment of patients with relapsed or refractory PTCL.

NF Energy Saving Corp. (NASDAQ: NFEC) last week announced its financial results for the year ended December 31, 2011, posting total revenues of $14.93 million and net income of $2.05 million. “The 2011 fiscal year was marked by a profitable year and continued construction of its new manufacturing facilities, phase one of which was completed during the year,” commented Gang Li, chairman of NFEC.

NFEC soared 95.83% to $2.35 on volume of over 3.54 million shares. The stock has a 52-week range of $0.46 – $4.82. NFEC has advanced 170.08% in the last five days and 191.93% in the last month. Year-to-date, the stock is down 27.91%.

NF Energy Saving is a China-based provider of integrated energy conservation solutions utilizing energy-saving equipment, technical services and energy management re-engineering project operations to provide energy saving services to clients. The company’s customers are mainly concentrated in the electrical generation (large-scale thermal power generation, hydroelectric power, and nuclear power), water supply, and heat supply industries. The majority of revenues are from energy efficient flow control solutions including equipment and energy efficiency project services.

Bed Bath & Beyond Inc. (NASDAQ: BBBY) rocketed 9.84% to $72.75 today, setting a new 52-week high, after the housewares retailer on Wednesday announced strong results for its fourth quarter, which ended February 25. The company posted earnings of $1.48 a share on revenue of $2.73 billion, both topping analysts’ expectations of $1.33 a share and sales of $2.66 billion, according to a poll by FactSet Research.

BBBY added $5.62, or 8.49%, to close at $71.85 on volume of over 10.64 million shares. The stock has risen 7.69% in the last five days; 16.39% in the last month; and 46.93% year-to-date.

Bed Bath & Beyond, together with its subsidiaries, is a chain of retail stores, operating under the names of Bed Bath & Beyond, Christmas Tree Shops, Harmon, Harmon Face Values and buybuy BABY. In addition, the company is a partner in a joint venture which operates retail stores in Mexico under the name Home & More. The company sells a wide assortment of domestics merchandise and home furnishings. Domestics merchandise includes categories such as bed linens and related items, bath items and kitchen textiles. Home furnishings include categories such as kitchen and tabletop items, fine tabletop, basic housewares, general home furnishings, consumables and certain juvenile products.

China Recycling Energy Corp. (NASDAQ: CREG) hit a new high of $3.30 before closing the session at $2.05, up 36.55% from the prior day’s closing price. Over 2.04 million shares exchanged hands today, dwarfing the 30-day average of just 19K. In the last five trading sessions, the stock has gained 70.83%.

The company late last month announced its results for the full year 2011, highlighting a 34% to $21.45 million increase in net income.

China Recycling Energy, based in Xi’an, China, provides environmentally friendly waste-to-energy technologies to recycle industrial byproducts for steel mills, cement factories and coke plants in China. Byproducts include heat, steam, pressure, and exhaust to generate large amounts of lower-cost electricity and reduce the need for outside electrical sources. The company’s management and engineering teams have over 20 years of experience in industrial energy recovery in China.

• Need fast service and cheap rates from a broker? Buy stock online at my favorite brokerage
• See today’s top stock picks and market analysis
• Want more? Check out the message board buzz for these stocks
• See what newsletters are recommending these stock picks
• Get breaking news alerts on these stocks: http://thestockmarketwatch.com/
• This newsletter has been helping traders make a killing on these stocks. Click here for a 25% discount offer.

About BeaconEquity.com

BeaconEquity.com is committed to producing the highest-quality insight and analysis of small-cap stocks, emerging technology stocks, hot penny stocks and helping investors make informed decisions. Our focus is primarily OTC stocks in the stock market today, which have traditionally been shunned by Wall Street. We have particular expertise with renewable energy stocks, biotech stocks, oil stocks, green energy stocks and internet stocks. There are many hot penny stock opportunities present in the OTC market everyday and we seek to exploit these hot stock gains for our members before the average daytrader is aware of them.

Beacon Equity Group Disclaimer

This newsletter is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. Beaconequity.com is a wholly-owned subsidiary of BlueWave Advisors.

While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.